Gene Mapping Gives Rise To Drugs That Rebuild Tissue

The logical outcome of gene mapping is nigh. Biotechnology companies are using genetic information to design new drugs that may go beyond merely slowing or stopping a disease process to inducing the regeneration or repair of damaged tissue. Looking past the conventional drug targets of enzymes and gene-coupled receptors, researchers are seeking out molecules in the pathways along which biochemical signals are transferred. In some cases, their work has led to compounds--now in clinical trials or

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

The groundwork for these advances has been laid over recent years by genetic mapping--the arrangement of mutable sites on a chromosome as deduced from genetic recombination experiments. This mapping has revealed remarkable similarities, or conservation, in the genes of a few organisms up and down the evolutionary tree. By altering genes from conserved areas of the genome in such organisms as yeast, nematode worms, fruit flies, zebra fish, mice, and cats, developmental biologists are elucidating the biochemical pathways and are finding new points of intervention for drugs to treat humans.

Photo: Exelixis FLY MODEL: Researchers at Exelixis Pharmaceuticals insert a human disease gene in the eye of a fruit fly to investigate the signaling pathway as a normal eye (left), degenerates into a "rough" eye. "Mass genetic mapping has put a library of just about all the known genes into the public domain," notes Geoffrey Duyk, chief scientific officer of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Steve Bunk

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours